Indeed, since decreased p120ctn protein expression significantly overlaps with EGFR overexpression in ESCC [31], it may be an explanation why cetuximab clinical trials failed in treating patients with ESCC [52]. This evidence concerns the gene CTNND1 and esophageal squamous cell carcinoma.